Effects of Intravenous Benzo[a]Pyrene Dose Administration on Levels of Exposure Biomarkers, DNA Adducts, and Gene Expression in Rats

REFERENCES

• Baird, W. M., Hooven, L. A., and Mahadevan, B. 2005. Carcinogenic polycyclic aromatic hydrocarbon–DNA adducts and mechanism of action. Environ. Mol. Mutagen. 45: 106 –114.
   PubMed Web of Science ®Google Scholar
• Barbeau, D., Maitre, A.,and Marques, M. 2011. Highly sensitive routine method for urinary 3-hydroxybenzo[a]pyrene quantitation using liquid chromatography–fluorescence detection and automated off-line solid phase extraction. Analyst 136: 1183 –1191.
   PubMed Web of Science ®Google Scholar
• Bartosiewicz, M., Penn, S., and Buckpitt, A. 2001. Applications of gene arrays in environmental toxicology: Fingerprints of gene regulation associated with cadmium chloride, benzo(a)pyrene, and trichloroethylene. Environ. Health Perspect. 109: 71 –74.
   PubMed Web of Science ®Google Scholar
• Bloom, D. A., and Jaiswal, A. K. 2003. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278: 44675 –44682.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., Dodd, C., and Viau, C. 1994. Improved procedure for the high-performance liquid chromatographic determination of monohydroxylated PAH metabolites in urine. J. Anal. Toxicol. 18: 261 –264.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., Krishnan, K., and Viau, C. 1998. Kinetics of tissue distribution and elimination of pyrene and 1-hydroxypyrene following intravenous administration of [14C]pyrene in rats. Toxicol. Sci. 46: 11 –20.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., and Viau, C. 1996. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites. Toxicol. Appl. Pharmacol. 139: 301 –309.
   PubMed Web of Science ®Google Scholar
• Bouchard, M., and Viau, C. 1997. Urinary excretion of benzo[a]pyrene metabolites following intravenous, oral, and cutaneous benzo[a]pyrene administration. Can. J. Physiol. Pharmacol. 75: 185 –192.
   PubMed Web of Science ®Google Scholar
• Burczynski, M. E., and Penning, T. M. 2000. Genotoxic polycyclic aromatic hydrocarbon ortho-quinones generated by aldo-keto reductases induce CYP1A1 via nuclear translocation of the aryl hydrocarbon receptor. Cancer Res. 60: 908 –915.
   PubMed Web of Science ®Google Scholar
• Castorena-Torres, F., Bermudez de Leon, M., Cisneros, B., Zapata-Perez, O., Salinas, J. E., and Albores, A. 2008. Changes in gene expression induced by polycyclic aromatic hydrocarbons in the human cell lines HepG2 and A549. Toxicol. In Vitro 22: 411 –421.
   PubMed Web of Science ®Google Scholar
• Chung, J. Y., Kim, J. Y., Lee, S. G., Kim, Y. J., Park, J. E., Hong, Y. P., Chun, Y. J., Park, Y. C., Oh, S., Yoo, K. S., Yoo, Y. H., and Kim, J. M. 2007. Abundance of aryl hydrocarbon receptor potentiates benzo[a]pyrene-induced apoptosis in Hepa1c1c7 cells via CYP1A1 actication. Toxicology 235: 62 –72.
   PubMed Web of Science ®Google Scholar
• Divi, R. L., Beland, F. A., Fu, P. P., Von Tungeln, L. S., Schoket, B., Camara, J. E., Ghei, M., Rothman, N., Sinha, R., and Poirier, M. C. 2002. Highly sensitive chemiluminescence immunoassay for benzo[a]pyrene-DNA adducts: Validation by comparison with other methods, and use in human biomonitoring. Carcinogenesis 23: 2043 –2049.
   PubMed Web of Science ®Google Scholar
• Gendre, C., Lafontaine, M., Delsaut, P., and Simon, P. 2004. Exposure to polycyclic aromatic hydrocarbons and excretion of urinary 3-hydroxybenzo(a)pyrene: Assessment of an appropriate sampling time. Polycyclic Aromatic Compounds 24: 433 –439.
   Web of Science ®Google Scholar
• Harrigan, J. A., McGarrigle, B. P., Sutter, T. R., and Olson, J. R. 2006. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene. Toxicol. In Vitro 20: 426 –438.
   PubMed Web of Science ®Google Scholar
• Hecht, S. S., Carmella, S. G., Villalta, P. W., and Hochalter, J. B. 2010. Analysis of phenanthrene and benzo[a]pyrene tetraol enantiomers in human urine: relevance to the bay region diol epoxide hypothesis of benzo[a]pyrene carcinogenesis and to biomarker studies. Chem. Res. Toxicol. 23: 900 –908.
   PubMed Web of Science ®Google Scholar
• Heredia-Ortiz, R., and Bouchard, M. 2013. Understanding the linked kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker of exposure using physiologically-based pharmacokinetic modelling in rats. J. Pharmacokinet. Pharmacodyn. 40: 669 –682.
   PubMed Web of Science ®Google Scholar
• Heredia-Ortiz, R., Maître, A., Lafontaine, M., and Bouchard, M. 2014. Use of physiologically-based pharmacokinetic modeling to simulate the profiles of 3-hydroxybenzo(a)pyrene in workers exposed to polycyclic aromatic hydrocarbons. PLoS One 9: e102570.
   PubMedGoogle Scholar
• Hockley, S. L., Arlt, V. M., Brewer, D., Giddings, I., and Phillips, D. H. 2006. Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2. BMC Genomics 7: 260.
   PubMed Web of Science ®Google Scholar
• Hockley, S. L., Arlt, V. M., Brewer, D., Te Poele, R., Workman, P., Giddings, I., and Phillips, D. H. 2007. AHR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines. Chem. Res. Toxicol. 20: 1797 –1810.
   PubMed Web of Science ®Google Scholar
• IARC. 2010. Polycyclic aromatic hydrocarbons. Monogr. Eval. Carcinogen. Risk Chem. Man. Lyon, France.
   Google Scholar
• Kaspar, J. W., Niture, S. K. and Jaiswal, A. K. 2009. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radical Biol. Med. 47: 1304 –1309.
   PubMed Web of Science ®Google Scholar
• Kim, J. H., Stansbury, K. H., Walker, N. J., Trush, M., Strickland, P. T., and Sutter, T. R. 1998. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19: 1847 –1853.
   PubMed Web of Science ®Google Scholar
• Lemaire, P., Sturve, J., Forlin, L., and Livingstone, D. R. 1996. Studies on aromatic hydrocarbon quinone metabolism and DT-diaphorase function in liver of fish species. Mar. Environ. Res. 42: 317 –321.
   Web of Science ®Google Scholar
• Leroyer, A., Jeandel, F., Maitre, A., Howsam, M., Deplanque, D., Mazzuca, M., and Nisse, C. 2010. 1-Hydroxypyrene and 3-hydroxybenzo[a]pyrene as biomarkers of exposure to PAH in various environmental exposure situations. Sci. Total Environ. 408: 1166 –1173.
   PubMed Web of Science ®Google Scholar
• Lesage, J., Perrault, G., and Durand, P. 1987. Evaluation of worker exposure to polycyclic aromatic hydrocarbons. Am. Ind. Hyg. Assoc. J. 48: 753 –759.
   PubMed Web of Science ®Google Scholar
• Likhachev, A. J., Beniashvili, D., Bykov, V. J., Dikun, P. P., Tyndyk, M. L., Savochkina, I. V., Yermilov, V. B., and Zabezhinski, M. A. 1992. Biomarkers for individual susceptibility to carcinogenic agents: Excretion and carcinogenic risk of benzo[a]pyrene metabolites. Environ. Health Perspect. 98: 211 –214.
   PubMed Web of Science ®Google Scholar
• Lu, X., Shao, J., Li, H., and Yu, Y. 2009. Early whole-genome transcriptional response induced by benzo[a]pyrene diol epoxide in a normal human cell line. Genomics 93: 332 –342.
   PubMed Web of Science ®Google Scholar
• Lu, X., Shao, J., Li, H., and Yu, Y. 2010. Temporal gene expression changes induced by a low concentration of benzo[a]pyrene diol epoxide in a normal human cell line. Mutat. Res. 684: 74 –80.
   PubMed Web of Science ®Google Scholar
• Marie-Desvergne, C., Maitre, A., Bouchard, M., Ravanat, J. L., and Viau, C. 2010. Evaluation of DNA adducts, DNA and RNA oxidative lesions, and 3-hydroxybenzo(a)pyrene as biomarkers of DNA damage in lung following intravenous injection of the parent compound in rats. Chem. Res. Toxicol. 23: 1207 –1214.
   PubMed Web of Science ®Google Scholar
• Marie, C., Bouchard, M., Heredia-Ortiz, R., Viau, C., and Maître, A. 2010. A toxicokinetic study to elucidate 3-hydroxybenzo(a)pyrene atypical urinary excretion profile following intravenous injection of benzo(a)pyrene in rats. J. Appl. Toxicol. 30: 402 –410.
   PubMed Web of Science ®Google Scholar
• Moir, D., Viau, A., Chu, I., Withey, J., and McMullen, E. 1998. Pharmacokinetics of benzo[a]pyrene in the rat. J. Toxicol. Environ. Health A 53: 507 –530.
   PubMed Web of Science ®Google Scholar
• Molliere, M., Foth, H., Kahl, R. and Kahl, G. F. 1987. Comparison of benzo(a)pyrene metabolism in isolated perfused rat lung and liver. Arch. Toxicol. 60: 270 –277.
   PubMed Web of Science ®Google Scholar
• Murray, G. I., Melvin, W. T., Greenlee, W. F., and Burke, M. D. 2001. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol. 41: 297 –316.
   PubMed Web of Science ®Google Scholar
• Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. 2004. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279: 23847 –23850.
   PubMed Web of Science ®Google Scholar
• Nguyen, P. M., Park, M. S., Chow, M., Chang, J. H., Wrischnik, L., and Chan, W. K. 2010. Benzo[a]pyrene increases the Nrf2 content by downregulating the Keap1 message. Toxicol. Sci. 116: 549 –561.
   PubMed Web of Science ®Google Scholar
• Nguyen, T., Nioi, P., and Pickett, C. B. 2009. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284, 13291 –13295.
   PubMed Web of Science ®Google Scholar
• Park, J. H., Mangal, D., Frey, A. J., Harvey, R. G., Blair, I. A., and Penning, T. M. 2009. Aryl hydrocarbon receptor facilitates DNA strand breaks and 8-oxo-2′-deoxyguanosine formation by the aldo-keto reductase product benzo[a]pyrene-7,8-dione. J. Biol. Chem. 284: 29725 –29734.
   PubMed Web of Science ®Google Scholar
• Park, S. Y., Lee, S. M., Ye, S. K., Yoon, S. H., Chung, M. H., and Choi, J. 2006. Benzo[a]pyrene-induced DNA damage and p53 modulation in human hepatoma HepG2 cells for the identification of potential biomarkers for PAH monitoring and risk assessment. Toxicol. Lett. 167: 27 –33.
   PubMed Web of Science ®Google Scholar
• Pathirana, S., Connell, D. W., and Vowles, P. D. 1994. Distribution of polycyclic aromatic hydrocarbons (PAHs) in an urban roadway system. Ecotoxicol. Environ. Safety 28: 256 –269.
   PubMed Web of Science ®Google Scholar
• Penning, T. M., Ohnishi, S. T., Ohnishi, T., and Harvey, R. G. 1996. Generation of reactive oxygen species during the enzymatic oxidation of polycyclic aromatic hydrocarbon trans-dihydrodiols catalyzed by dihydrodiol dehydrogenase. Chem. Res. Toxicol. 9: 84 –92.
   PubMed Web of Science ®Google Scholar
• Pitot, H. C., and Dragan, Y. P. 1996. Chemical carcinogenesis. In Casarett and Doull’s toxicology, ed. C. D. Klaassen, 201 –267. New York, NY: Mc Graw-Hill.
   Google Scholar
• Qin, G., and Meng, Z. 2006. The expressions of protooncogenes and CYP1A in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene. Regul. Toxicol. Pharmacol. 45: 36 –43.
   PubMed Web of Science ®Google Scholar
• Qin, G., and Meng, Z. 2010. Expression of oncogenes and tumor suppressor genes in lungs of rats exposed to sulfur dioxide and benzo(a)pyrene. Inhal. Toxicol. 22: 322 –329.
   PubMed Web of Science ®Google Scholar
• Ramesh, A., Inyang, F., Hood, D. B., Archibong, A. E., Knuckles, M. E., and Nyanda, A. M. 2001. Metabolism, bioavailability, and toxicokinetics of benzo(alpha)pyrene in F-344 rats following oral administration. Exp. Toxicol. Pathol. 53: 275 –290.
   PubMed Web of Science ®Google Scholar
• Ramesh, A., and Knuckles, M. E. 2006. Dose-dependent benzo(a)pyrene [B(a)P]-DNA adduct levels and persistence in F-344 rats following subchronic dietary exposure to B(a)P. Cancer Lett. 240: 268 –278.
   PubMed Web of Science ®Google Scholar
• Sadikovic, B., and Rodenhiser, D. I. 2006. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells. Toxicol. Appl. Pharmacol. 216: 458 –468.
   PubMed Web of Science ®Google Scholar
• Shackelford, R. E., Kaufmann, W. K., and Paules, R. S. 1999. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ. Health Perspect. 107(suppl. 1): 5 –24.
   PubMed Web of Science ®Google Scholar
• Shimada, T. 2006. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab. Pharmacokinet. 21: 257 –276.
   PubMed Web of Science ®Google Scholar
• Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y. and Ishikawa, T. 2000. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 97: 779 –782.
   PubMed Web of Science ®Google Scholar
• Tekpli, X., Rivedal, E., Gorria, M., Landvik, N. E., Rissel, M., Dimanche-Boitrel, M. T., Baffet, G., Holme, J. A., and Lagadic-Gossmann, D. 2010. The B[a]P-increased intercellular communication via translocation of connexin-43 into gap junctions reduces apoptosis. Toxicol. Appl. Pharmacol. 242: 231 –240.
   PubMed Web of Science ®Google Scholar
• Uziel, M., and Haglund, R. 1988. Persistence of benzo[a]pyrene and 7,8-dihydro-7,8-dihydroxybenzo[a] pyrene in Fischer 344 rats: Time distribution of total metabolites in blood, urine and feces. Carcinogenesis 9: 233 –238.
   PubMed Web of Science ®Google Scholar
• van de Wiel, J. A., Fijneman, P. H., Duijf, C. M., Anzion, R. B., Theuws, J. L., and Bos, R. P. 1993. Excretion of benzo[a]pyrene and metabolites in urine and feces of rats: Influence of route of administration, sex and long-term ethanol treatment. Toxicology 80: 103 –115.
   PubMed Web of Science ®Google Scholar
• van Delft, J. H., Mathijs, K., Staal, Y. C., van Herwijnen, M. H., Brauers, K. J., Boorsma, A., and Kleinjans, J. C. 2010. Time series analysis of benzo[A]pyrene-induced transcriptome changes suggests that a network of transcription factors regulates the effects on functional gene sets. Toxicol. Sci. 117: 381 –392.
   PubMed Web of Science ®Google Scholar
• Venugopal, R., and Jaiswal, A.K. 1996. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc. Natl. Acad. Sci. USA 93: 14960 –14965.
   PubMed Web of Science ®Google Scholar
• Viau, C., Bouchard, M., Carrier, G., Brunet, R., and Krishnan, K. 1999. The toxicokinetics of pyrene and its metabolites in rats. Toxicol. Lett. 108: 201 –207.
   PubMed Web of Science ®Google Scholar
• Wang, J. J., Frazer, D. G., Law, B., and Lewis, D. M. 2003. Identification and quantification of urinary benzo[a]pyrene and its metabolites from asphalt fume exposed mice by microflow LC coupled to hybrid quadrupole time-of-flight mass spectrometry. Analyst 128: 864 –870.
   PubMed Web of Science ®Google Scholar
• White, P. A. 2002. The genotoxicity of priority polycyclic aromatic hydrocarbons in complex mixtures. Mutat. Res. 515: 85 –98.
   PubMed Web of Science ®Google Scholar
• Won Lee, H. S. S., Hong, J. E., Pyo, H., and Kim, Y. 2003. Studies on the analysis of benzo(a)pyrene and its metabolites in biological samples by using high performance liquid chromatograpy/fluorescence detection and gas chromatography/mass spectrometry. Bull. Korean Chem. Soc. 24: 559 –565.
   Web of Science ®Google Scholar
• Wu, J., Ramesh, A., Nayyar, T., and Hood, D. B. 2003. Assessment of metabolites and AhR and CYP1A1 mRNA expression subsequent to prenatal exposure to inhaled benzo(a)pyrene. Int. J. Dev. Neurosci. 21: 333 –346.
   PubMed Web of Science ®Google Scholar
• Xue, W. and Warshawsky, D. 2005. Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A review. Toxicol. Appl. Pharmacol. 206: 73 –93.
   PubMed Web of Science ®Google Scholar
• Yauk, C. L., Jackson, K., Malowany, M., and Williams, A. 2011. Lack of change in microRNA expression in adult mouse liver following treatment with benzo(a)pyrene despite robust mRNA transcriptional response. Mutat. Res. 722: 131 –139.
   PubMed Web of Science ®Google Scholar
• Zhao, W., and Ramos, K. S. 1998. Modulation of hepatocyte gene expression by the carcinogen benzo[a]pyrene. Toxicol. In Vitro 12: 395 –402.
   PubMed Web of Science ®Google Scholar